Efficacy and Safety of Treatment With an Anti-M2e Monoclonal Antibody in Experimental Human Influenza-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Efficacy and Safety of Treatment With an Anti-M2e Monoclonal Antibody in Experimental Human Influenza

Published:2014-10-03 Issue:7 Volume:211 Page:1038-1044
ISSN:0022-1899
Container-title:Journal of Infectious Diseases
language:en
Short-container-title:J Infect Dis.

Author:

Ramos Eleanor L.,Mitcham Jennifer L.,Koller Teri D.,Bonavia Aurelio,Usner Dale W.,Balaratnam Ganesh,Fredlund Paul,Swiderek Kristine M.

Publisher

Oxford University Press (OUP)

Subject

Infectious Diseases,Immunology and Allergy

Link

http://academic.oup.com/jid/article-pdf/211/7/1038/5089660/jiu539.pdf

Reference17 articles.

1. Prospects for Universal Influenza Virus Vaccine

2. Human antibodies reveal a protective epitope that is highly conserved among human and nonhuman influenza A viruses

3. Influenza A virus M2 protein: monoclonal antibody restriction of virus growth and detection of M2 in virions;Zebedee;J Virol,1988

4. Treatment of Influenza Virus-Infected SCID Mice with Nonneutralizing Antibodies Specific for the Transmembrane Proteins Matrix 2 and Neuraminidase Reduces the Pulmonary Virus Titer but Fails to Clear the Infection

5. Passively transferred monoclonal antibody to the M2 protein inhibits influenza A virus replication in mice;Treanor;J Virol,1990

Cited by 109 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. H1N1 nanobody development and therapeutic efficacy verification in H1N1-challenged mice;Biomedicine & Pharmacotherapy;2024-07

2. Retracted and republished from: “The current state of research on influenza antiviral drug development: drugs in clinical trial and licensed drugs”;mBio;2024-05-08

3. Passive immunotherapies for the next influenza pandemic;Reviews in Medical Virology;2024-04-18

4. Recent Advances, Approaches and Challenges in the Development of Universal Influenza Vaccines;Influenza and Other Respiratory Viruses;2024-03

5. Monoclonal Antibodies and Hyperimmune Immunoglobulins in the Next Pandemic;Current Topics in Microbiology and Immunology;2024

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3